4//SEC Filing
Nassif David W. 4
Accession 0001636050-22-000020
CIK 0001636050other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 5:05 PM ET
Size
5.8 KB
Accession
0001636050-22-000020
Insider Transaction Report
Form 4
Nassif David W.
Principal Financial Officer
Transactions
- Award
Restricted Stock Units
2022-02-08+546,500→ 546,500 total→ Common Stock (546,500 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents the right to receive one share of the Issuer's common stock.
- [F2]One-third of the restricted stock units shall vest on February 8, 2023, February 8, 2024 and February 8, 2025, subject to the Reporting Person providing continuous service to the Issuer through each such date.
Documents
Issuer
Sio Gene Therapies Inc.
CIK 0001636050
Entity typeother
Related Parties
1- filerCIK 0001636975
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 5:05 PM ET
- Size
- 5.8 KB